rts logo

Are we looking at the next big move in TG Therapeutics Inc (TGTX)?

TG Therapeutics Inc (NASDAQ: TGTX) is 5.15% higher on its value in year-to-date trading and has touched a low of $6.46 and a high of $31.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TGTX stock was last observed hovering at around $17.32 in the last trading session, with the day’s gains setting it 0.64%.

Currently trading at $17.96, the stock is 18.77% and 16.81% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.74 million and changing 3.70% at the moment leaves the stock 35.86% off its SMA200. TGTX registered -41.86% loss for a year compared to 6-month gain of 75.73%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 27.65% loss in the last 1 month and extending the period to 3 months gives it a 28.93%, and is 4.54% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.12% over the week and 5.62% over the month.

TG Therapeutics Inc (TGTX) has around 264 employees, a market worth around $2.78B and $289.33M in sales. Current P/E ratio is 81.45 and Fwd P/E is 30.31. Profit margin for the company is 14.24%. Distance from 52-week low is 178.02% and -43.73% from its 52-week high. The company has generated returns on investments over the last 12 months (15.24%).

with sales reaching $65.89M over the same period.The EPS is expected to shrink by -138.27% this year, but quarterly earnings will post 32.10% year-over-year. Quarterly sales are estimated to grow 277.60% in year-over-year returns.

TG Therapeutics Inc (TGTX) Top Institutional Holders

The shares outstanding are 151.42M, and float is at 139.77M with Short Float at 27.08%.

TG Therapeutics Inc (TGTX) Insider Activity

The most recent transaction is an insider sale by Lonial Sagar,the company’sDirector. SEC filings show that Lonial Sagar sold 5,000 shares of the company’s common stock on Mar 13 ’24 at a price of $15.94 per share for a total of $79675.0. Following the sale, the insider now owns 0.11 million shares.

TG Therapeutics Inc disclosed in a document filed with the SEC on Mar 12 ’24 that Charney Laurence N (Director) sold a total of 22,000 shares of the company’s common stock. The trade occurred on Mar 12 ’24 and was made at $15.97 per share for $0.35 million. Following the transaction, the insider now directly holds 0.22 million shares of the TGTX stock.

Still, SEC filings show that on Jan 05 ’24, Charney Laurence N (Director) disposed off 17,500 shares at an average price of $19.03 for $0.33 million. The insider now directly holds 237,229 shares of TG Therapeutics Inc (TGTX).

Related Posts